Mechanism of resistance to chemotherapy in triple negative breast cancer

被引：0
作者：
Loi, S. [1 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30064-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SA 2.4
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [31] Neoadjuvant Versus Adjuvant Chemotherapy for Triple Negative Breast Cancer
    Kennedy, Carlie R.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (01) : 52 - 57
  • [32] Pembrolizumab plus Chemotherapy for triple-negative Breast Cancer
    Judith Lorenz, Kuenzell
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (11) : 1114 - 1114
  • [33] Immunomodulation with dexamethasone in neoadjuvant chemotherapy for triple negative breast cancer
    Goldstein, Daniel
    Kassem, Mahmoud
    Quiroga, Dionisia
    Miah, Abdul
    Vargo, Craig
    Shinde, Namrata Vilas
    Berger, Michael
    Williams, Nicole
    Stover, Daniel
    Sardesai, Sagar
    Lustberg, Maryam
    Ramaswamy, Bhuvaneswari
    Tozbikian, Gary
    Schnell, Patrick
    Cherian, Mathew
    CANCER RESEARCH, 2021, 81 (04)
  • [34] Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
    Mayer, Erica L.
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (28) : 3369 - +
  • [35] Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: An Observational Study
    Shao, Zhiying
    Chaudhri, Shalini
    Guo, Meng
    Zhang, Longzhen
    Rea, Daniel
    ONCOLOGY RESEARCH, 2016, 23 (06) : 291 - 302
  • [36] Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy
    Aldrich, Jeffrey
    Canning, Madison
    Bhave, Manali
    CLINICAL BREAST CANCER, 2023, 23 (08) : 832 - 834
  • [37] Immunotherapy in Combination with Chemotherapy for Triple-negative Breast Cancer
    Elizabeth, Melendez Solano
    Cristina, Stevens Barron Jazmin
    Christian, Chapa Gonzalez
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (04) : 431 - 439
  • [38] Neoadjuvant chemotherapy regimens for triple negative breast cancer patients
    Gigolaeva, L.
    Krivorotko, P.
    Zhiltsova, E.
    Dashyan, G.
    Chadjimatova, S.
    Pesotckiy, R.
    Emelyanov, A.
    Semiglazov, V.
    BREAST, 2019, 44 : S70 - S70
  • [39] Potential chemotherapy options in the triple negative subtype of breast cancer
    Altundag, Kadri
    Harputluoglu, Hakan
    Aksoy, Sercan
    Gullu, Ibrahim H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1294 - 1295
  • [40] Platinum-based chemotherapy in triple negative breast cancer
    Eckstein, N.
    Haas, B.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (07) : 333 - 336
12345